World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
59
Citations
16033
World Ranking
3227
National Ranking
87

Overview

Manuel Comabella is affiliated with the Vall d'Hebron Institut de Recerca in Spain. Their research focuses primarily on medical science, with an emphasis on pathology and forensic medicine, neurology, molecular biology, immunology, and oncology. The majority of their work centers on multiple sclerosis research studies, peripheral neuropathies and disorders, and related fields such as cytokine signaling pathways, neuroinflammation, and immune cell mechanisms.

The scientist has an extensive publication record, contributing notably to journals specializing in neurology and immunology. Frequent venues for their work include Multiple Sclerosis Journal, Neurology Neuroimmunology & Neuroinflammation, Neurology, Frontiers in Immunology, and Journal of Neuroimmunology.

Their recent published papers exemplify a focus on biomarkers and clinical applications in neurological disorders, as well as multiple sclerosis progression and related immune responses. Selected recent works include:

  • Neurofilaments as biomarkers in neurological disorders - towards clinical application, 2024, Nature Reviews Neurology
  • Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple Sclerosis, 2022, JAMA Neurology
  • Serum neurofilament light as a biomarker in progressive multiple sclerosis, 2020, Neurology
  • COVID-19 in multiple sclerosis patients: susceptibility, severity risk factors and serological response, 2020, European Journal of Neurology
  • NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients, 2020, Brain

Collaboration plays a significant role in their research activities. Frequent coauthors include Xavier Montalbán, Luciana Midaglia, Jordi Río, Mar Tintoré, and Georgina Arrambide. These collaborations reflect sustained joint efforts in studying neurological disorders, especially multiple sclerosis.

The main scientific topics addressed in their work comprise:

  • Multiple Sclerosis Research Studies
  • Peripheral Neuropathies and Disorders
  • Polyomavirus and related diseases
  • Cytokine Signaling Pathways and Interactions
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Studies on Chitinases and Chitosanases
  • T-cell and B-cell Immunology

Manuel Comabella's publication portfolio spans a range of subfields that include 68 publications in pathology and forensic medicine, 39 in neurology, 31 in molecular biology, 28 in immunology, and 22 in oncology. Their ongoing research contributes to the understanding of disease biomarkers, immune mechanisms, and the clinical progression of neurological conditions, particularly multiple sclerosis.

Best Publications

  • Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

    Stephen Sawcer;Garrett Hellenthal;Matti Pirinen;Chris C. A. Spencer

  • Neurofilaments as biomarkers in neurological disorders

    Michael Khalil;Charlotte E. Teunissen;Markus Otto;Fredrik Piehl

  • Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility

    Unknown

  • A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

    Charlotte Teunissen;Axel Petzold;Jeffrey L. Bennett;Frode S. Berven

  • Defining high, medium and low impact prognostic factors for developing multiple sclerosis

    Mar Tintore;Àlex Rovira;Jordi Río;Susana Otero-Romero

  • Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis

    M Tintoré;A Rovira;J Río;C Tur

  • Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients

    Jordi Río;Carlos Nos;Mar Tintoré;Nieves Téllez

  • Baseline MRI predicts future attacks and disability in clinically isolated syndromes.

    M. Tintoré;A. Rovira;J. Río;C. Nos

  • Consensus guidelines for lumbar puncture in patients with neurological diseases

    Sebastiaan Engelborghs;Ellis Niemantsverdriet;Hanne Struyfs;Kaj Blennow

  • Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

    J. Kuhle;G. Disanto;R. Dobson;R. Adiutori

  • New diagnostic criteria for multiple sclerosis: application in first demyelinating episode.

    M. Tintoré;A. Rovira;J. Río;C. Nos

  • Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis

    Manuel Comabella;Marta Fernández;Roland Martin;Stephanie Rivera-Vallvé

  • Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica

    Patrick Waters;Markus Reindl;Albert Saiz;Kathrin Schanda

  • Measures in the first year of therapy predict the response to interferon beta in MS.

    J Río;J Castilló;A Rovira;M Tintoré

  • Body fluid biomarkers in multiple sclerosis.

    Manuel Comabella;Xavier Montalban

  • Elevated Epstein–Barr virus‐encoded nuclear antigen‐1 immune responses predict conversion to multiple sclerosis

    Jan D. Lünemann;Mar Tintoré;Brady Messmer;Brady Messmer;Till Strowig

  • Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy

    Manuel Comabella;Konstantine Balashov;Shohreh Issazadeh;Derek Smith

  • A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis

    M. Comabella;J. D. Lünemann;J. Río;A. Sánchez

  • A consensus protocol for the standardisation of cerebrospinal fluid collection and biobanking

    Charlotte E. Teunissen;Axel Petzold;Jeffrey L. Bennett;Frode S. Berven

  • Transcription-Based Prediction of Response to IFNβ Using Supervised Computational Methods

    Sergio E Baranzini;Parvin Mousavi;Jordi Rio;Stacy J Caillier

  • Brainstem lesions in clinically isolated syndromes.

    M. Tintore;A. Rovira;G. Arrambide;R. Mitjana

  • Plasma osteopontin levels in multiple sclerosis.

    Manuel Comabella;Imma Pericot;Robert Goertsches;Carlos Nos

  • Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes

    Ester Cantó;Mar Tintoré;Luisa M Villar;Carme Costa

  • Genome-Wide Pharmacogenomic Analysis of the Response to Interferon Beta Therapy in Multiple Sclerosis

    Esther Byun;Stacy J. Caillier;Xavier Montalban;Pablo Villoslada

  • Immunopathogenesis of multiple sclerosis

    Manuel Comabella;Samia J. Khoury

  • FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS

    Yawei Liu;Robert Carlsson;Manuel Comabella;Jun Yang Wang

  • Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis

    Charlotte Teunissen;Til Menge;Ayse Altintas;José C Álvarez-Cermeño

  • Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls

    Sergio E. Baranzini;Pouya Khankhanian;Nikolaos A. Patsopoulos;Michael Li

  • Tumor necrosis factor alpha (TNF-α), anti-TNF-α and demyelination revisited: an ongoing story.

    Ana Caminero;Manuel Comabella;Xavier Montalban

  • Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk

    Mitja Mitrovič;Nikolaos A. Patsopoulos;Ashley H. Beecham;Theresa Dankowski

Frequent Co-Authors

Xavier Montalban
Xavier Montalban Autonomous University of Barcelona
Alex Rovira
Alex Rovira Autonomous University of Barcelona
Jorge R. Oksenberg
Jorge R. Oksenberg University of California, San Francisco
José Antonio del Río
José Antonio del Río University of Barcelona
Bernhard Hemmer
Bernhard Hemmer Technical University of Munich
Finn Sellebjerg
Finn Sellebjerg Copenhagen University Hospital
Frauke Zipp
Frauke Zipp Johannes Gutenberg University of Mainz
Roland Martin
Roland Martin University of Zurich
Hanne F. Harbo
Hanne F. Harbo Oslo University Hospital
Daniela Galimberti
Daniela Galimberti University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students studying Microbiology in the USA, exploring related healthcare fields can broaden career prospects. One increasingly popular area is medical coding and billing, which connects healthcare services with administrative precision. Pursuing a certified professional coder salary reveals promising earnings and steady demand in this sector.

Another vital field is health information management, which focuses on organizing and maintaining patient data. Aspiring professionals can check average healthcare information management salary details to understand the financial benefits and potential growth in this career pathway.

Many students prefer online degree options that balance flexibility with accreditation standards. The best online health information management degree cahiim accredited programs provide reputable education critical for those aiming for leadership roles in health data management.

For those seeking quicker routes into the healthcare administration workforce, accelerated options like the medical billing and coding certificate online accelerated programs offer credentials within months, positioning graduates for immediate employment in medical offices and hospitals.

Best Scientists Citing Manuel Comabella

Trending Scientists

Recently Published Articles